Globus Medical (GMED) : Money flow in the Globus Medical (GMED) stock was negative (1.1 million) on Monday, which shows that the investors used the strength in the stock price to reduce their holdings. The total traded value on upticks was $0.2 million, compared to $1.31 million on downticks. The total uptick to downtick ratio was 0.16, indicating the underlying weakness in the stock. Even in block trades, money flow was negative ($1.12 million), indicating selling on the strength. Downtick transaction value in block trades amounted to $1.12 million, indicating persistent selling. Globus Medical (GMED) traded $0.09 higher at $24.86 gaining 0.36% over the previous days close.
Globus Medical, Inc. is up 3.39% in the last 3-month period. Year-to-Date the stock performance stands at -11.14%. Globus Medical, Inc. has dropped 0.4% in the last five trading days, however, the shares have posted positive gains of 2.28% in the last 4 weeks. In a related news, The director, of Globus Medical Inc, Liptak Robert had unloaded 15,300 shares at $27.5 per share in a transaction on January 4, 2016. The total value of transaction was $420,750. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
Globus Medical (NYSE:GMED): On Mondays trading session , Opening price of the stock was $24.81 with an intraday high of $24.97. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $24.51. However, the stock managed to close at $24.72, a loss of 0.20% for the day. On the previous day, the stock had closed at $24.77. The total traded volume of the day was 622,313 shares.
Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders and spine disorders. Its products consist of two categories: Innovative Fusion and Disruptive Technologies. Innovative Fusion products comprise fusion products to treat various spinal disorders for the entire spine and can be used in various surgical approaches. Disruptive Technologies represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. The Companys portfolio of Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques, as well as treatment alternatives, including motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and biomaterials technologies, as well as interventional pain management solutions.